ARTICLE | Distillery Therapeutics
Therapeutics: Peroxisome proliferator activated receptor (PPAR) α; PPARγ coactivator 1-α (PPARGC1A, PGC-1a)
January 15, 2015 8:00 AM UTC
Studies in mice and patient samples suggest stimulating fatty acid oxidation (FAO) could help treat kidney fibrosis. In samples from patients with chronic kidney disease, mRNA levels of key FAO enzyme...